Clinical trial NCT03908463: KOMATE Registry: Korean Multicenter Angioplasty Team
Official title: KOMATE Registry: Korean Multicenter Angioplasty Team
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Coronary Artery Disease
Acute Coronary Syndrome
Myocardial Infarction
Percutaneous Coronary Intervention
Lead sponsor: Yonsei University
Sponsor class: OTHER
First posted: 2019-04-09
Enrollment: 20000
Sex: ALL
Minimum age (years): 19
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The patients who undergo percutaneous coronary intervention group/Cohort Description: The patients who undergo percutaneous coronary intervention will be enrolled.

Brief summary: The investigators will enroll the patients who underwent PCI and was based on real world clinical practice to collect the data regarding demographic, clinical, procedural information and clinical outcome using case report forms.


Eligibility criteria: Inclusion Criteria:

* 1. Patients older than 19 years
* 2. Patients who undergo percutaneous coronary intervention

Exclusion Criteria:

* 1. Refuse to participate
* 2. Pregnant women or women with potential childbearing

Primary outcomes:
measure: Target lesion revascularization
timeFrame: Up to 20 years
measure: Target vessel revascularization
timeFrame: Up to 20 years
measure: Stent thrombosis
timeFrame: Up to 20 years
measure: Myocardial infarction
timeFrame: Up to 20 years
measure: Death
timeFrame: Up to 20 years
measure: Non-target vessel revascularization
timeFrame: Up to 20 years
measure: Cerebrovascular accident
timeFrame: Up to 20 years
measure: Major bleeding
timeFrame: Up to 20 years
measure: Cardiovascular readmission
timeFrame: Up to 20 years
Secondary outcomes:
Other outcomes:
Locations:
city: Seoul
country: Korea, Republic of
facility: Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu 120-752 Seoul, South Korea
Study officials:
References:
citation: Cho S, Kang DY, Kim JS, Park DW, Kim IS, Kang TS, Ahn JM, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Jang Y, Hong MK, Park SJ. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease. Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):245-252. doi: 10.1016/j.rec.2022.07.007. Epub 2022 Jul 27. English, Spanish.
citation: Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH, Park JK, Shin S, Moon JY, Won H, Suh Y, Cho JR, Cho YH, Oh SJ, Lee BK, Hong SJ, Shin DH, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y. Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study. J Am Heart Assoc. 2021 Apr 20;10(8):e020079. doi: 10.1161/JAHA.120.020079. Epub 2021 Apr 10.
citation: Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH, Park JK, Shin S, Moon JY, Won H, Suh Y, Cho JR, Cho YH, Oh SJ, Lee BK, Hong SJ, Shin DH, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents. J Am Heart Assoc. 2020 Jun 2;9(11):e016218. doi: 10.1161/JAHA.119.016218. Epub 2020 May 16.